• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy.从单次人体心脏活检中同时分离出3种不同的心脏干细胞群
Circ Res. 2017 Jul 7;121(2):113-124. doi: 10.1161/CIRCRESAHA.116.310494. Epub 2017 Apr 26.
2
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.
3
Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies.直接从心脏活检中分离和扩增功能成熟的心脏祖细胞。
J Mol Cell Cardiol. 2010 Aug;49(2):312-21. doi: 10.1016/j.yjmcc.2010.02.019. Epub 2010 Mar 4.
4
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells.患者特征和细胞来源决定了分离的人心脏祖细胞的数量。
Circulation. 2009 Dec 22;120(25):2559-66. doi: 10.1161/CIRCULATIONAHA.109.849588. Epub 2009 Dec 7.
5
Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy.建立用于干细胞治疗的人类心脏C-试剂盒阳性祖细胞的分离和扩增方案。
Transplant Proc. 2013 Jan-Feb;45(1):420-6. doi: 10.1016/j.transproceed.2012.08.017.
6
Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit Cells.病理刺激决定心脏C-kit细胞的谱系定向
Circulation. 2017 Dec 12;136(24):2359-2372. doi: 10.1161/CIRCULATIONAHA.117.030137. Epub 2017 Oct 11.
7
C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment.C-kit+ 心脏祖细胞表现出间充质标志物,并具有优先的心血管分化潜能。
Cardiovasc Res. 2011 Feb 1;89(2):362-73. doi: 10.1093/cvr/cvq292. Epub 2010 Sep 10.
8
The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.Sca-1+/CD31-心脏祖细胞群在心肌梗死后左心室重构中的作用。
Stem Cells. 2006 Jul;24(7):1779-88. doi: 10.1634/stemcells.2005-0386. Epub 2006 Apr 13.
9
Human cardiac stem cells.人类心脏干细胞。
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14068-73. doi: 10.1073/pnas.0706760104. Epub 2007 Aug 20.
10
Isolation and expansion of adult cardiac stem cells from human and murine heart.从人和小鼠心脏中分离并扩增成年心脏干细胞
Circ Res. 2004 Oct 29;95(9):911-21. doi: 10.1161/01.RES.0000147315.71699.51. Epub 2004 Oct 7.

引用本文的文献

1
Sources and applications of endothelial seed cells: a review.内皮祖细胞的来源与应用:综述。
Stem Cell Res Ther. 2024 Jun 18;15(1):175. doi: 10.1186/s13287-024-03773-6.
2
Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications.用于治疗应用的无动物源培养基中扩增和鉴定人角膜缘基质/间充质干细胞。
Stem Cell Res Ther. 2023 Apr 15;14(1):89. doi: 10.1186/s13287-023-03299-3.
3
Adipogenic Signaling Promotes Arrhythmia Substrates before Structural Abnormalities in TMEM43 ARVC.在TMEM43致心律失常性右室心肌病中,脂肪生成信号在结构异常之前促进心律失常底物形成。
J Pers Med. 2022 Oct 9;12(10):1680. doi: 10.3390/jpm12101680.
4
Cell Therapy in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭的细胞治疗
Card Fail Rev. 2022 Mar 21;8:e08. doi: 10.15420/cfr.2021.21. eCollection 2022 Jan.
5
Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells.用干细胞阐明致心律失常性右室心肌病。
Birth Defects Res. 2022 Oct 1;114(16):948-958. doi: 10.1002/bdr2.2010. Epub 2022 Apr 9.
6
Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.丝裂霉素处理的内皮细胞和平滑肌细胞适用于安全的组织工程方法。
Front Bioeng Biotechnol. 2022 Mar 11;10:772981. doi: 10.3389/fbioe.2022.772981. eCollection 2022.
7
Comparative Analysis of Mesenchymal Stem Cell Cultivation in Fetal Calf Serum, Human Serum, and Platelet Lysate in 2D and 3D Systems.二维和三维系统中胎牛血清、人血清及血小板裂解液培养间充质干细胞的比较分析
Front Bioeng Biotechnol. 2021 Jan 15;8:598389. doi: 10.3389/fbioe.2020.598389. eCollection 2020.
8
Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration.用于心血管疾病的异种和基于干细胞的疗法:猪细胞的基因工程及其在心脏再生中的应用
Int J Mol Sci. 2020 Dec 18;21(24):9686. doi: 10.3390/ijms21249686.
9
Enhancing myocardial repair with CardioClusters.用 CardioClusters 增强心肌修复。
Nat Commun. 2020 Aug 7;11(1):3955. doi: 10.1038/s41467-020-17742-z.
10
Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.人心肌间充质干细胞在疾病中重塑,并可调节心律失常基质。
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008740. doi: 10.1161/CIRCEP.120.008740. Epub 2020 Jul 29.

本文引用的文献

1
Pim1 Kinase Overexpression Enhances ckit Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.Pim1激酶过表达增强猪心肌梗死后ckit心脏干细胞的心脏修复能力。
J Am Coll Cardiol. 2016 Dec 6;68(22):2454-2464. doi: 10.1016/j.jacc.2016.09.925.
2
Characterization and Expression of Senescence Marker in Prolonged Passages of Rat Bone Marrow-Derived Mesenchymal Stem Cells.大鼠骨髓间充质干细胞长期传代过程中衰老标志物的表征与表达
Stem Cells Int. 2016;2016:8487264. doi: 10.1155/2016/8487264. Epub 2016 Aug 4.
3
Isolation, Characterization and Growth Kinetic Comparison of Bone Marrow and Adipose Tissue Mesenchymal Stem Cells of Guinea Pig.豚鼠骨髓和脂肪组织间充质干细胞的分离、鉴定及生长动力学比较
Int J Stem Cells. 2016 May 30;9(1):115-23. doi: 10.15283/ijsc.2016.9.1.115.
4
Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy.重复给予心脏祖细胞比单次给予明显更有效:细胞治疗的新范例。
Circ Res. 2016 Aug 19;119(5):635-51. doi: 10.1161/CIRCRESAHA.116.308937. Epub 2016 Jun 30.
5
Hiding inside? Intracellular expression of non-glycosylated c-kit protein in cardiac progenitor cells.隐匿于内?心脏祖细胞中非糖基化c-kit蛋白的细胞内表达。
Stem Cell Res. 2016 May;16(3):795-806. doi: 10.1016/j.scr.2016.04.017. Epub 2016 Apr 23.
6
Low c-Kit Expression Level Induced by Stem Cell Factor Does Not Compromise Transplantation of Hematopoietic Stem Cells.干细胞因子诱导的低c-Kit表达水平不会损害造血干细胞的移植。
Biol Blood Marrow Transplant. 2016 Jul;22(7):1167-1172. doi: 10.1016/j.bbmt.2016.03.017. Epub 2016 Mar 31.
7
Challenges in identifying the best source of stem cells for cardiac regeneration therapy.确定用于心脏再生治疗的最佳干细胞来源所面临的挑战。
Stem Cell Res Ther. 2015 Mar 13;6(1):26. doi: 10.1186/s13287-015-0010-8.
8
Isolation and characterization of Human Mesenchymal Stromal Cells Derived from Placental Decidua Basalis; Umbilical cord Wharton's Jelly and Amniotic Membrane.人源骨髓基质细胞的分离与鉴定,源于胎盘底蜕膜;脐带华通氏胶和羊膜。
Pak J Med Sci. 2014 Sep;30(5):1022-6. doi: 10.12669/pjms.305.4537.
9
Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.自体骨髓干细胞试验与射血分数改善的差异(DAMASCENE):加权回归和荟萃分析。
BMJ. 2014 Apr 28;348:g2688. doi: 10.1136/bmj.g2688.
10
Rejuvenation of human cardiac progenitor cells with Pim-1 kinase.Pim-1 激酶对人心肌祖细胞的再生作用。
Circ Res. 2013 Oct 25;113(10):1169-79. doi: 10.1161/CIRCRESAHA.113.302302. Epub 2013 Sep 17.

从单次人体心脏活检中同时分离出3种不同的心脏干细胞群

Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy.

作者信息

Monsanto Megan M, White Kevin S, Kim Taeyong, Wang Bingyan J, Fisher Kristina, Ilves Kelli, Khalafalla Farid G, Casillas Alexandria, Broughton Kathleen, Mohsin Sadia, Dembitsky Walter P, Sussman Mark A

机构信息

From the San Diego Heart Research Institute, San Diego State University, CA (M.M.M., K.S.W., T.K., B.J.W., K.F., K.I., F.G.K., A.C., K.B., S.M., M.A.S.); and Sharp Memorial Hospital, San Diego, CA (W.P.D.).

出版信息

Circ Res. 2017 Jul 7;121(2):113-124. doi: 10.1161/CIRCRESAHA.116.310494. Epub 2017 Apr 26.

DOI:10.1161/CIRCRESAHA.116.310494
PMID:28446444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5555597/
Abstract

RATIONALE

The relative actions and synergism between distinct myocardial-derived stem cell populations remain obscure. Ongoing debates on optimal cell population(s) for treatment of heart failure prompted implementation of a protocol for isolation of multiple stem cell populations from a single myocardial tissue sample to develop new insights for achieving myocardial regeneration.

OBJECTIVE

Establish a robust cardiac stem cell isolation and culture protocol to consistently generate 3 distinct stem cell populations from a single human heart biopsy.

METHODS AND RESULTS

Isolation of 3 endogenous cardiac stem cell populations was performed from human heart samples routinely discarded during implantation of a left ventricular assist device. Tissue explants were mechanically minced into 1 mm pieces to minimize time exposure to collagenase digestion and preserve cell viability. Centrifugation removes large cardiomyocytes and tissue debris producing a single cell suspension that is sorted using magnetic-activated cell sorting technology. Initial sorting is based on tyrosine-protein kinase Kit (c-Kit) expression that enriches for 2 c-Kit cell populations yielding a mixture of cardiac progenitor cells and endothelial progenitor cells. Flowthrough c-Kit mesenchymal stem cells are positively selected by surface expression of markers CD90 and CD105. After 1 week of culture, the c-Kit population is further enriched by selection for a CD133 endothelial progenitor cell population. Persistence of respective cell surface markers in vitro is confirmed both by flow cytometry and immunocytochemistry.

CONCLUSIONS

Three distinct cardiac cell populations with individualized phenotypic properties consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells can be successfully concurrently isolated and expanded from a single tissue sample derived from human heart failure patients.

摘要

原理

不同心肌来源干细胞群体之间的相对作用及协同作用仍不清楚。关于治疗心力衰竭的最佳细胞群体的持续争论促使实施一项方案,从单个心肌组织样本中分离多个干细胞群体,以获得实现心肌再生的新见解。

目的

建立一种可靠的心脏干细胞分离和培养方案,以便从单个人类心脏活检样本中持续产生3种不同的干细胞群体。

方法与结果

从左心室辅助装置植入过程中常规丢弃的人类心脏样本中分离出3种内源性心脏干细胞群体。将组织外植体机械切碎成1毫米的小块,以尽量减少胶原酶消化的时间暴露并保持细胞活力。离心去除大的心肌细胞和组织碎片,产生单细胞悬液,使用磁激活细胞分选技术进行分选。初始分选基于酪氨酸蛋白激酶Kit(c-Kit)表达,富集2种c-Kit细胞群体,产生心脏祖细胞和内皮祖细胞的混合物。通过c-Kit间充质干细胞的标志物CD90和CD105的表面表达进行阳性选择。培养1周后,通过选择CD133内皮祖细胞群体进一步富集c-Kit群体。通过流式细胞术和免疫细胞化学证实了体外各自细胞表面标志物的持续性。

结论

可以成功地从源自人类心力衰竭患者的单个组织样本中同时分离并扩增出三种具有与心脏祖细胞、内皮祖细胞和间充质干细胞一致的个性化表型特性的不同心脏细胞群体。